BRIEF-Cipher pharmaceuticals sees Q2 total revenue of about $11.7 mln

Wed Aug 3, 2016 9:03am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 3 (Reuters) - Cipher Pharmaceuticals Inc

* Cipher pharmaceuticals announces preliminary q2 2016 results highlighted by 30+% revenue growth and $3.0+million cash from operations

* Sees net loss of about $3.4 million, or $0.13 per basic share for q2

* Q2 revenue view $11.1 million -- Thomson Reuters I/B/E/S

* Sees q2 total revenue of approximately $11.7 million, an increase of more than 30% from $8.8 million in q2 2015 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)